- Home
- PEN vs TEM Comparison
PEN vs TEM Comparison
Compare PEN & TEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- TEM
- Stock Information
- Founded
- PEN 2004
- TEM 2015
- Country
- PEN United States
- TEM United States
- Employees
- PEN N/A
- TEM N/A
- Industry
- PEN Medical/Dental Instruments
- TEM
- Sector
- PEN Health Care
- TEM
- Exchange
- PEN Nasdaq
- TEM NYSE
- Market Cap
- PEN 10.1B
- TEM 11.9B
- IPO Year
- PEN 2015
- TEM 2024
- Fundamental
- Price
- PEN $238.44
- TEM $56.88
- Analyst Decision
- PEN Strong Buy
- TEM Buy
- Analyst Count
- PEN 16
- TEM 12
- Target Price
- PEN $302.40
- TEM $65.09
- AVG Volume (30 Days)
- PEN 404.1K
- TEM 9.4M
- Earning Date
- PEN 07-29-2025
- TEM 08-05-2025
- Dividend Yield
- PEN N/A
- TEM N/A
- EPS Growth
- PEN N/A
- TEM N/A
- EPS
- PEN 1.08
- TEM N/A
- Revenue
- PEN $1,240,100,000.00
- TEM $803,315,000.00
- Revenue This Year
- PEN $14.60
- TEM $81.57
- Revenue Next Year
- PEN $14.24
- TEM $24.86
- P/E Ratio
- PEN $221.29
- TEM N/A
- Revenue Growth
- PEN 13.17
- TEM 42.93
- 52 Week Low
- PEN $148.00
- TEM $31.36
- 52 Week High
- PEN $310.00
- TEM $91.45
- Technical
- Relative Strength Index (RSI)
- PEN 26.12
- TEM N/A
- Support Level
- PEN $240.12
- TEM N/A
- Resistance Level
- PEN $253.94
- TEM N/A
- Average True Range (ATR)
- PEN 5.78
- TEM 0.00
- MACD
- PEN -0.66
- TEM 0.00
- Stochastic Oscillator
- PEN 10.05
- TEM 0.00
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
About TEM TEMPUS AI INC
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.